Early Life
Christine Franken is one of the three daughters of Horst Sartorius, who passed on a 50% stake in the biopharmaceutical firm Sartorius AG after his death in 1998. Her great-grandfather, Florenz Sartorius, founded the firm in 1870 to manufacture analytical balances used in laboratories.
Rise to Success
Sartorius AG went public in 1990, and today, the company manufactures pharmaceutical and laboratory equipment. This background in the pharmaceutical industry provided the foundation for the family's wealth.
Key Business Strategies
The core of the Franken family's wealth is centered around Sartorius AG, a major player in the biopharmaceutical and laboratory equipment sector. The company's strategy involves the development and production of technologies and solutions used in pharmaceutical research, development, and manufacturing processes.
Philanthropy
Information on Christine Franken's specific philanthropic initiatives is not readily available in the provided search results.